secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0001193125-25-245206
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Viridian expects ~$490.9M cash as of Sept 30, 2025; preliminary, unaudited
--------------------------------------------------------------------------

- Preliminary cash, equivalents, and marketable securities of ~$490.9M as of September 30, 2025.
- Figure is unaudited and may materially differ from final Q3 2025 balance sheet upon close.
- Full Q3 2025 financial results not yet finalized; no revenue or EPS guidance provided.
- Disclosure intended to provide early liquidity visibility ahead of complete financial report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312525245206/0001193125-25-245206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312525245206/d12120d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-245206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer